ACTIVATED AND EXPANDED NATURAL KILLER (NKAE) CELLS KILL MULTIPLE MYELOMA (MM) CLONOGENIC PLASMA CELLS THROUGH NKG2D AND NKP30 RECEPTORS AND THEIR LIGANDS

被引：0
|
作者：
Leivas, A. [1 ]
Risueno, R. M. [2 ]
Perez-Martinez, A. [3 ]
Fernandez-Casanova, L. [4 ]
Lahuerta, J. J. [1 ]
Martinez-Lopez, J. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Hematol Serv, Madrid, Spain
[2] Josep Carreras Leukemia Res Inst, Leukemia Stem Cell Grp, Barcelona, Spain
[3] Hosp Univ La Paz, Pediat Oncohematol Serv, Madrid, Spain
[4] Ctr Nacl Invest Oncol, Madrid, Spain
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P332
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [41] Immunomodulatory effect of NEDD8-activating enzyme inhibition in Multiple Myeloma: upregulation of NKG2D ligands and sensitization to Natural Killer cell recognition
    Sara Petillo
    Cristina Capuano
    Rosa Molfetta
    Cinzia Fionda
    Abdelilah Mekhloufi
    Chiara Pighi
    Fabrizio Antonangeli
    Alessandra Zingoni
    Alessandra Soriani
    Maria Teresa Petrucci
    Ricciarda Galandrini
    Rossella Paolini
    Angela Santoni
    Marco Cippitelli
    Cell Death & Disease, 12
  • [42] Differential modulation of natural killer cell cytotoxicity by 17β-estradiol and prolactin through the NKG2D/NKG2DL axis in cervical cancer cells
    Godoy-Pacheco, Alejandro
    Garcia-Chagollan, Mariel
    Ramirez-De-Arellano, Adrian
    Hernandez-Silva, Christian David
    Villegas-Pineda, Julio Cesar
    Ramirez-Lopez, Inocencia Guadalupe
    Zepeda-Nuno, Jose Sergio
    Aguilar-Lemarroy, Adriana
    Pereira-Suarez, Ana Laura
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [43] Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands
    Geng Li
    Shahryar Khoshtinat Nikkhoi
    Arash Hatefi
    Medical Oncology, 40
  • [44] Ex vivo activated and expanded CD8+T cells recognize malignant cells through a TCR independent and NKG2D dependent pathway
    Verneris, MR
    Karami, M
    Baker, J
    Jasawal, A
    Negrin, RS
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 19 - 19
  • [45] Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands
    Li, Geng
    Nikkhoi, Shahryar Khoshtinat
    Hatefi, Arash
    MEDICAL ONCOLOGY, 2023, 40 (04)
  • [46] Histamine reduces susceptibility to natural killer cells via down-regulation of NKG2D ligands on human monocytic leukaemia THP-1 cells
    Nagai, Yasuhiro
    Tanaka, Yukinori
    Kuroishi, Toshinobu
    Sato, Ryutaro
    Endo, Yasuo
    Sugawara, Shunji
    IMMUNOLOGY, 2012, 136 (01) : 103 - 114
  • [47] Ataxiatelangiectasia mutated kinase-mediated upregulation of NKG2D ligands on leukemia cells by resveratrol results in enhanced natural killer cell susceptibility
    Espinoza, J. Luis
    Takami, Akiyoshi
    Trung, Ly Q.
    Nakao, Shinji
    CANCER SCIENCE, 2013, 104 (06) : 657 - 662
  • [48] Increased co-expression of the natural killer cell receptor NKG2D and further natural killer cell receptors on CD4+ T cells in granulomatosis with polyangiitis
    Schueler, S.
    Wolters, S.
    Pitann, S.
    Kabelitz, D.
    Lamprecht, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (02) : S183 - S184
  • [49] In Vitro Expanded NK Cells Have Increased Natural Cytotoxity Receptors, TRAIL and NKG2D Expression, and Superior Tumor Cytotoxicity Compared to Short-Term IL-2-Activated NK Cells
    Berg, Maria
    Lundqvist, Andreas
    Betters, Dawn
    Childs, Richard W.
    BLOOD, 2009, 114 (22) : 192 - 192
  • [50] Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors
    Hu, Liangshan
    Cao, Donglin
    Li, Yuhua
    He, Yanjie
    Guo, Kunyuan
    CANCER BIOLOGY & THERAPY, 2012, 13 (07) : 516 - 526
12345